MPM Capital
Venture capital25 people tracked
Investment thesis
MPM Capital (MPM BioImpact) invests in private and public biotechnology companies across the drug development process, aiming to turn scientific discoveries into new medicines. The firm, with offices in California and Massachusetts, also creates companies directly, such as circular RNA developer Orna Therapeutics, and its team combines backgrounds in research, drug development, and commercialization.
Team · 25 people
from the firm's website
Frequently asked questions
- What sectors does MPM Capital focus on?
- MPM Capital focuses on Biotech.
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.